Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography.
Saved in:
| Title: | Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography. |
|---|---|
| Authors: | Dickmann CGF; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., McDonald AF; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Huynh N; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Rigopoulos A; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Liu Z; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Guo N; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Osellame LD; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Gorman MA; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au., Parker MW; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.; ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia.; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, VIC 3065, Australia., Gan HK; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.; Faculty of Medicine, University of Melbourne, Parkville, Australia., Ackermann U; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au., White JM; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au. |
| Source: | Chemical communications (Cambridge, England) [Chem Commun (Camb)] 2023 Mar 09; Vol. 59 (21), pp. 3126-3129. Date of Electronic Publication: 2023 Mar 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 9610838 Publication Model: Electronic Cited Medium: Internet ISSN: 1364-548X (Electronic) Linking ISSN: 13597345 NLM ISO Abbreviation: Chem Commun (Camb) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36809538 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dickmann+CGF%22">Dickmann CGF</searchLink>; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22McDonald+AF%22">McDonald AF</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Huynh+N%22">Huynh N</searchLink>; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Rigopoulos+A%22">Rigopoulos A</searchLink>; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Guo+N%22">Guo N</searchLink>; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Osellame+LD%22">Osellame LD</searchLink>; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Gorman+MA%22">Gorman MA</searchLink>; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.<br /><searchLink fieldCode="AU" term="%22Parker+MW%22">Parker MW</searchLink>; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.; ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia.; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, VIC 3065, Australia.<br /><searchLink fieldCode="AU" term="%22Gan+HK%22">Gan HK</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.; Faculty of Medicine, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Ackermann+U%22">Ackermann U</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.<br /><searchLink fieldCode="AU" term="%22Burvenich+IJG%22">Burvenich IJG</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.<br /><searchLink fieldCode="AU" term="%22White+JM%22">White JM</searchLink>; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229610838%22">Chemical communications (Cambridge, England)</searchLink> [Chem Commun (Camb)] 2023 Mar 09; Vol. 59 (21), pp. 3126-3129. <i>Date of Electronic Publication: </i>2023 Mar 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+Society+of+Chemistry%22">Royal Society of Chemistry </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9610838 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1364-548X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213597345%22">13597345 </searchLink><i>NLM ISO Abbreviation: </i>Chem Commun (Camb) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36809538 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1039/d2cc04813b Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3126 Titles: – TitleFull: Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dickmann CGF – PersonEntity: Name: NameFull: McDonald AF – PersonEntity: Name: NameFull: Huynh N – PersonEntity: Name: NameFull: Rigopoulos A – PersonEntity: Name: NameFull: Liu Z – PersonEntity: Name: NameFull: Guo N – PersonEntity: Name: NameFull: Osellame LD – PersonEntity: Name: NameFull: Gorman MA – PersonEntity: Name: NameFull: Parker MW – PersonEntity: Name: NameFull: Gan HK – PersonEntity: Name: NameFull: Scott AM – PersonEntity: Name: NameFull: Ackermann U – PersonEntity: Name: NameFull: Burvenich IJG – PersonEntity: Name: NameFull: White JM IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 03 Text: 2023 Mar 09 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1364-548X Numbering: – Type: volume Value: 59 – Type: issue Value: 21 Titles: – TitleFull: Chemical communications (Cambridge, England) Type: main |
| ResultId | 1 |
